
The company also plans to expand its phase 2 BELLA study to include three new study arms

Approximately 7,500 people are diagnosed with ovarian cancer every year in the UK

Approximately 20,890 cases of the disease are expected to be diagnosed in the US this year

Approximately 6,000 to 8,000 women in the US are living with low-grade serous ovarian cancer

Approximately 20,000 cases of the disease are diagnosed in the US every year

An estimated 7,500 new cases of the disease were diagnosed in the UK between 2017 and 2019

Ovarian cancer is the seventh most common cancer in women globally

ESMO 2024 comes with the debut of 2 new, exciting symposia hosted by the MedscapeLIVE! team. The symposia build on nearly 30 years of Medscape’s experience and excellence in both...

The deal includes a next-generation ADC being evaluated as a treatment for ovarian cancer and other solid tumours

The company recently gained access to the therapy through its $10.1bn acquisition of ImmunoGen

Approximately 7,400 new cases of the disease are diagnosed in the UK every year

The agreement grants the company access to FDA-approved ovarian cancer drug Elahere